Goldman Sachs analyst Yaron Kinar reinstated Marsh & McLennan with a Neutral and $98 price target.

RBC Capital raised the firm's price target on Marsh McLennan to $210 from $208 and keeps a Sector Perform rating on the shares after its Q1 earnings beat. The company's organic growth rate has picked up over the past few quarters, and the solid top-line momentum in the business should remain intact during 2024 with some additional M&A opportunities, the analyst tells investors in a research note. The margin expansion pace for Q1 slowed relative to the recent quarters, but the management expects the margin pace to be higher in the second half of 2024, RBC added.